IBB icon

iShares Biotechnology ETF
IBB

Overview Fund Activity

232 hedge funds and large institutions have $2.26B invested in iShares Biotechnology ETF in 2013 Q2 according to their latest regulatory filings, with 232 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
232
Holders Change
+232
Holders Change %
–
% of All Funds
7.57%
Holding in Top 10
10
Holding in Top 10 Change
+10
Holding in Top 10 Change %
%
% of All Funds
0.33%
New
232
Increased
–
Reduced
–
Closed
–
Calls
$127M
Puts
$212M
Net Calls
-$85.3M
Net Calls Change
-$85.3M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
ECM
226
Exchange Capital Management
Michigan
$11K 195 +195 New
SHWM
227
Smith & Howard Wealth Management
Georgia
$10K 168 +168 New
GG
228
Gofen & Glossberg
Illinois
$10K 177 +177 New
PSI
229
Pinnacle Summer Investments
Virginia
$10K 180 +180 New
CCT
230
Capital City Trust
Florida
$10K 180 +180 New
SPL
231
Smart Portfolios LLC
Washington
$7.48K 129 +129 New
CTC
232
Central Trust Company
Missouri
$5K 87 +87 New
CA
233
CapWealth Advisors
Tennessee
$3K 60 +60 New
PA
234
Perceptive Advisors
New York
– – – –
WMSA
235
Weiss Multi-Strategy Advisers
New York
– – – –
PC
236
Passport Capital
California
– – – –
KCM
237
Kingdon Capital Management
New York
– – – –
ST
238
Spot Trading
Illinois
– – – –
PG
239
PEAK6 Group
Illinois
– – – –
HVC
240
Healthcare Value Capital
New Jersey
– – – –
HT
241
HAP Trading
New York
– – – –
6 7 8 9
10